Literature DB >> 25822751

Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation.

István A Krizbai, Ákos Gasparics, Péter Nagyőszi, Csilla Fazakas, Judit Molnár, Imola Wilhelm, Rita Bencs, László Rosivall, Attila Sebe.   

Abstract

Cancer progression towards metastasis follows a defined sequence of events described as the metastatic cascade. For extravasation and transendothelial migration metastatic cells interact first with endothelial cells. Yet the role of endothelial cells during the process of metastasis formation and extravasation is still unclear, and the interaction between metastatic and endothelial cells during transendothelial migration is poorly understood. Since tumor cells are well known to express TGF-β, and the compact endothelial layer undergoes a series of changes during metastatic extravasation (cell contact disruption, cytoskeletal reorganization, enhanced contractility), we hypothesized that an EndMT may be necessary for metastatic extravasation. We demonstrate that primary cultured rat brain endothelial cells (BEC) undergo EndMT upon TGF-β1 treatment, characterized by the loss of tight and adherens junction proteins, expression of fibronectin, β1-integrin, calponin and α-smooth muscle actin (SMA). B16/F10 cell line conditioned and activated medium (ACM) had similar effects: claudin-5 down-regulation, fibronectin and SMA expression. Inhibition of TGF-β signaling during B16/F10 ACM stimulation using SB-431542 maintained claudin-5 levels and mitigated fibronectin and SMA expression. B16/F10 ACM stimulation of BECs led to phosphorylation of Smad2 and Smad3. SB-431542 prevented SMA up-regulation upon stimulation of BECs with A2058, MCF-7 and MDA-MB231 ACM as well. Moreover, B16/F10 ACM caused a reduction in transendothelial electrical resistance, enhanced the number of melanoma cells adhering to and transmigrating through the endothelial layer, in a TGF-β-dependent manner. These effects were not confined to BECs: HUVECs showed TGF-β-dependent SMA expression when stimulated with breast cancer cell line ACM. Our results indicate that an EndMT may be necessary for metastatic transendothelial migration, and this transition may be one of the potential mechanisms occurring during the complex phenomenon known as metastatic extravasation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25822751      PMCID: PMC4378947          DOI: 10.1371/journal.pone.0123845

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Notice of Republication

This article was republished on March 11, 2015, to replace incorrect figures in the PDF that were introduced during the production process. The publisher apologizes for the error. Please download this article again to view the correct version.
  1 in total

1.  Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation.

Authors:  István A Krizbai; Ákos Gasparics; Péter Nagyőszi; Csilla Fazakas; Judit Molnár; Imola Wilhelm; Rita Bencs; László Rosivall; Attila Sebe
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

  1 in total
  14 in total

Review 1.  Small heat shock proteins in ageing and age-related diseases.

Authors:  Nikolaos Charmpilas; Emmanouil Kyriakakis; Nektarios Tavernarakis
Journal:  Cell Stress Chaperones       Date:  2017-01-10       Impact factor: 3.667

2.  Quantitative proteomic analysis of the miR-148a-associated mechanisms of metastasis in non-small cell lung cancer.

Authors:  Dandan Chu; Jing Li; Hechun Lin; Xiao Zhang; Hongyu Pan; Lei Liu; Tao Yu; Mingxia Yan; Ming Yao
Journal:  Oncol Lett       Date:  2018-04-26       Impact factor: 2.967

Review 3.  Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases.

Authors:  Imola Wilhelm; Csilla Fazakas; Kinga Molnár; Attila G Végh; János Haskó; István A Krizbai
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-18       Impact factor: 6.200

4.  An In Vitro Platform to Study Reversible Endothelial-to-Mesenchymal Transition.

Authors:  Muthu Kumar Krishnamoorthi; Rajarajan A Thandavarayan; Keith A Youker; Arvind Bhimaraj
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

Review 5.  A bi-directional dialog between vascular cells and monocytes/macrophages regulates tumor progression.

Authors:  Victor Delprat; Carine Michiels
Journal:  Cancer Metastasis Rev       Date:  2021-03-30       Impact factor: 9.264

6.  Paracellular and transcellular migration of metastatic cells through the cerebral endothelium.

Authors:  Hildegard Herman; Csilla Fazakas; János Haskó; Kinga Molnár; Ádám Mészáros; Ádám Nyúl-Tóth; Gábor Szabó; Ferenc Erdélyi; Aurel Ardelean; Anca Hermenean; István A Krizbai; Imola Wilhelm
Journal:  J Cell Mol Med       Date:  2019-02-02       Impact factor: 5.310

7.  Response of the neurovascular unit to brain metastatic breast cancer cells.

Authors:  János Haskó; Csilla Fazakas; Kinga Molnár; Ádám Mészáros; Roland Patai; Gábor Szabó; Ferenc Erdélyi; Ádám Nyúl-Tóth; Fanni Győri; Mihály Kozma; Attila E Farkas; István A Krizbai; Imola Wilhelm
Journal:  Acta Neuropathol Commun       Date:  2019-08-19       Impact factor: 7.801

8.  Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model.

Authors:  Carolin J Curtaz; Constanze Schmitt; Saskia-Laureen Herbert; Jonas Feldheim; Nicolas Schlegel; Fabien Gosselet; Carsten Hagemann; Norbert Roewer; Patrick Meybohm; Achim Wöckel; Malgorzata Burek
Journal:  Fluids Barriers CNS       Date:  2020-04-22

9.  Defective Function of the Blood-Brain Barrier in a Stroke-Prone Spontaneously Hypertensive Rat: Evaluation in an In Vitro Cell Culture Model.

Authors:  Shinsuke Nakagawa; Hiroki Ohara; Masami Niwa; Kazuo Yamagata; Toru Nabika
Journal:  Cell Mol Neurobiol       Date:  2020-07-09       Impact factor: 5.046

Review 10.  TGFΒ-induced transcription in cancer.

Authors:  Gaia Cantelli; Eva Crosas-Molist; Mirella Georgouli; Victoria Sanz-Moreno
Journal:  Semin Cancer Biol       Date:  2016-08-30       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.